NEW YORK--(BUSINESS WIRE)--Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today announced that it will release its fourth quarter and full-year fiscal 2024 financial results after the closing of trading on the New York Stock Exchange on Wednesday, February 19, 2025. A conference call to discuss CMTG's financial results will be held on Thursday, February 20, 2025, at 10:00 a.m. ET. The conference call may be accessed by dialing 1-833-470-1428 and referencing the Claros Mortga.

image for news Claros Mortgage Trust, Inc. Announces Dates for Fourth Quarter 2024 Earnings Release and Conference Call

Hamilton Lane Announces Public Offering of Class A Common Stock — Neutral

HLNE   PRNewsWire — February 10, 2025

CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 1,572,536 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions.

image for news Hamilton Lane Announces Public Offering of Class A Common Stock

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=128507&wire=1 or contact Joseph E. Levi, Esq.

image for news Integral Ad Science Holding Corp. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights – IAS

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ModivCare Inc. (NASDAQ:MODV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/modivcare-inc-lawsuit-submission-form?prid=128504&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in ModivCare Inc. Lawsuit – MODV

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128505&wire=1 or contact Joseph E. Levi, Esq.

image for news ESSA Pharma Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EPIX

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=128508&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Neumora Therapeutics, Inc.(NMRA) Shareholders

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=128500&wire=1 or contact Joseph E. Levi, Esq.

image for news March 25, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CDLX

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128501&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=128499&wire=1 or contact Joseph E. Levi, Esq.

image for news MGPI LAWSUIT ALERT: Levi & Korsinsky Notifies MGP Ingredients, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=128503&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Grocery Outlet Holding Corp.(GO) Shareholders

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=128502&wire=1 or contact Joseph E. Levi, Esq.

image for news SAVA LAWSUIT ALERT: Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Equity Commonwealth Agrees to Sell 1225 Seventeenth Street Plaza — Neutral

EQC   Business Wire — February 10, 2025

CHICAGO--(BUSINESS WIRE)--Equity Commonwealth (NYSE: EQC) (“the Company”) announced today that it is under contract to sell its last remaining property, 1225 Seventeenth Street, a 709,402 square foot office property in Denver, Colorado, for a gross sale price of $132.5 million. The net purchase price is expected to be approximately $124.4 million after credits primarily for contractual lease costs. The buyer has completed due diligence, and the earnest money deposit is non-refundable. The sale.

image for news Equity Commonwealth Agrees to Sell 1225 Seventeenth Street Plaza

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today reported results for the quarter and year ended December 31, 2024.

image for news Apollo Commercial Real Estate Finance, Inc. Reports Fourth Quarter and Full Year 2024 Results

Beneficient Announces Third Quarter Fiscal 2025 Earnings Release and Webcast — Neutral

BENF   GlobeNewsWire — February 10, 2025

announced it will release Third Quarter Fiscal 2025 financial results on Thursday, February 13, 2025. Beneficient will also host a webcast on that day.

image for news Beneficient Announces Third Quarter Fiscal 2025 Earnings Release and Webcast

CoreCivic Reports Fourth Quarter and Full Year 2024 Financial Results — Neutral

CXW   GlobeNewsWire — February 10, 2025

Higher Occupancy and Cost Management Drive Strong Financial Performance Establishes 2025 Full Year Guidance

image for news CoreCivic Reports Fourth Quarter and Full Year 2024 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Universal Corporation (NYSE:UVV) (“Universal” or the “Company”), a global business-to-business agriproducts company, today is providing a financial and operational update for the third quarter of fiscal year 2025, including preliminary results for the quarter. Preston D. Wigner, Chairman, President, and Chief Executive Officer of Universal Corporation, stated, “Universal achieved solid results for the third quarter of fiscal year 2025, primarily driven by the str.

image for news Universal Corporation Provides Third Quarter Fiscal Year 2025 Financial and Operational Update

Darling Ingredients Inc. to Participate in Upcoming Conferences — Neutral

DAR   Business Wire — February 10, 2025

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR), the world's leading company turning food waste into sustainable products and producer of renewable energy, today announced that the company will participate in institutional investors meetings at the following conferences: BofA Securities Global Ag and Materials Conference, Fort Lauderdale, Fla. ­– February 26 Renewable Fuel Panel 2:45 p.m. ET Scotia Bank Howard Weil Energy Conference, Miami, Fla. – February 27 Fireside chat.

image for news Darling Ingredients Inc. to Participate in Upcoming Conferences

Mastercard Board of Directors Announces Quarterly Dividend — Neutral

MA   Business Wire — February 10, 2025

PURCHASE, N.Y.--(BUSINESS WIRE)--Mastercard (NYSE: MA) announced that its Board of Directors has declared a quarterly cash dividend of 76 cents per share.

image for news Mastercard Board of Directors Announces Quarterly Dividend

MAYFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--Materion Corporation (NYSE: MTRN) is scheduled to release its fourth quarter and full year 2024 financial results on February 19, 2025, before the opening of the New York Stock Exchange. The company will hold a conference call with investors at 10:00 AM ET that morning. Jugal Vijayvargiya, President and Chief Executive Officer, and Shelly Chadwick, Vice President, Finance and Chief Financial Officer, will represent Materion Corporation on the call. Confe.

image for news Materion Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results on February 19

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results — Neutral

MEDP   Business Wire — February 10, 2025

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Results Revenue for the three months ended December 31, 2024 increased 7.7% to $536.6 million, compared to $498.4 million for the comparable prior-year period. On a constant currency basis, revenue for the fourth quarter of 2024 increased 7.8% compared to the fourth quarter of 2023. Backlog as.

image for news Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results